Insulet Corporation (PODD)
NASDAQ: PODD · Real-Time Price · USD
266.58
+4.59 (1.75%)
Nov 20, 2024, 4:00 PM EST - Market closed
Insulet Employees
Insulet had 3,000 employees as of December 31, 2023. The number of employees increased by 400 or 15.38% compared to the previous year.
Employees
3,000
Change (1Y)
400
Growth (1Y)
15.38%
Revenue / Employee
$661,300
Profits / Employee
$140,300
Market Cap
18.70B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 3,000 | 400 | 15.38% |
Dec 31, 2022 | 2,600 | 300 | 13.04% |
Dec 31, 2021 | 2,300 | 400 | 21.05% |
Dec 31, 2020 | 1,900 | 550 | 40.74% |
Dec 31, 2019 | 1,350 | 181 | 15.48% |
Dec 31, 2018 | 1,169 | 312 | 36.41% |
Dec 31, 2017 | 857 | 217 | 33.91% |
Dec 31, 2016 | 640 | -7 | -1.08% |
Dec 31, 2015 | 647 | 128 | 24.66% |
Dec 31, 2014 | 519 | 41 | 8.58% |
Dec 31, 2013 | 478 | -60 | -11.15% |
Dec 31, 2012 | 538 | -38 | -6.60% |
Dec 31, 2011 | 576 | 266 | 85.81% |
Dec 31, 2010 | 310 | 34 | 12.32% |
Dec 31, 2009 | 276 | -18 | -6.12% |
Dec 31, 2008 | 294 | 47 | 19.03% |
Dec 31, 2007 | 247 | -47 | -15.99% |
Dec 31, 2006 | 294 | 47 | 19.03% |
Dec 31, 2005 | 247 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Labcorp Holdings | 67,000 |
Baxter International | 60,000 |
Quest Diagnostics | 48,000 |
Teva Pharmaceutical | 37,851 |
Align Technology | 21,610 |
Molina Healthcare | 18,000 |
The Cooper Companies | 15,000 |
BeiGene | 10,600 |
PODD News
- 14 hours ago - Insulet Corporation: Significant Opportunities, Significant Threats - I'm On The Sidelines - Seeking Alpha
- 1 day ago - Insulet Announces Omnipod® 5 System is Now Compatible with Abbott's FreeStyle Libre 2 Plus Sensor in the U.S. - Business Wire
- 6 days ago - Insulet to Present at Upcoming Investor Conferences - Business Wire
- 9 days ago - Buy, Sell, Or Hold Insulet (PODD) Stock? - Forbes
- 10 days ago - Top 4 Health Care Stocks That May Plunge This Quarter - Benzinga
- 13 days ago - Insulet Corporation (PODD) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 13 days ago - Insulet raises annual revenue forecast on strong demand for insulin pumps - Reuters
- 13 days ago - Insulet Reports Third Quarter 2024 Revenue Increase of 26% Year-Over-Year (25% Constant Currency1) - Business Wire